Controlling development through light: Next-generation tissue engineering

CyGenTiG is an international collaborative scientific programme to develop techniques for controlling living cells, including human cells, with light. Compared to drugs or physical interventions, light has huge advantages; it can be shone only when it is needed, it does can be controlled with high accuracy, and it can be switched off the instant its work is done. Although at an early stage, research into light-mediated control of cells, or ‘optogenetics’ as it is called, has the potential to be a major technology in healthcare of the future.

The project is funded under H2020 FET-Open research and innovation actions, Contract No: 801041.

Interdisciplinary Consortium

CyGenTiG is combining expert knowledge from leading research institutions and companies throughout Europe.


News


More News